tirzepatide patent eli lilly BPI labs is challenging the patent. This is a second challenge as Empower pharmacy was already challenging the patent. BPI includes additional imformation including a previous application showing GLP-1/GIP as In weight loss battle, Novo

Eli Lilly has partnered with Cipla to market its weight-loss drug tirzepatide in India under the brand name Yurpeak, offering weekly injectable doses to expand access to obesity care.

Prader-Willi syndrome presents unique metabolic challenges that standard weight loss approaches often fail to address

This comprehensive guide provides clear, actionable steps to understand and utilize semaglutide safely and effectively

A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health

It is none of those.Here are the 8 reasons i

Get insights on coverage, eligibility, and how to access these benefits effectively.